Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-06-000026

Sr. VP Research & Development acquired 2,201 shares (code I)

From the SEC's structured data for this filing

Trades in this filing

LEVY MICHAEL D · Sr. VP Research & Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2005-08-31 Other acquisition : show line 1 in the form +1,500 $6.33 $9,495 2,986 D
2006-05-31 Other acquisition : show line 2 in the form +701 $13.90 $9,744 3,687 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2006-08-01 Grant or award : show line 3 in the form Non Qualified Stock Option (right to buy) +74,025 $16.74 2016-08-01 74,025 74,025 D
2006-08-01 Grant or award : show line 4 in the form Incentive Stock Option (right to buy) +5,975 $16.74 2016-08-01 5,975 5,975 D
Loading xslF345X02/edgar.xml…